Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Coherus Oncology (CHRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
9 analysts
Options Flow (P/C)
—
Avg Consensus PT
$7
+1430.9%
Highest Price Target
$12
+2566.4%
Lowest Price Target
$1
+133.3%
Short Interest
8.5%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Guggenheim | Paul Jeng— | +1677.6% | $10 → $8 | Maintained | Buy |
| Oct 29, 2026 | HC Wainwright & Co. | Swayampakula Ramakanth— | +1455.4% | $7 | Assumes | Buy |